PROGRAMME   EHMSG Workshop

Friday, September 9, 2022

08.25 – 08.30 hrs   Welcome by EHMSG President Georgina Hold

08.30 – 09.30 hrs   Introductory Lectures 

 

08.30 - 09.00

Role of H. pylori at the gastro-esophageal junction
Ken McColl, Glasgow, United Kingdom

 

09.00 - 09.30

Dialogue between H. pylori and the gut microbiota
Emad El Omar, Sydney, Australia

 

09.30 – 11.00 hrs   Symposium 1: Maastricht VI

 

09.30 - 09.42
The  consensus concept            
Peter Malfertheiner, Munich, Germany
   

09.42 - 09.54
H. pylori infection in gastroduodenal and extragastric diseases
Theodore Rokkas, Athens, Greece

 

09.54 - 10.06
New Demands in H. pylori diagnosis  
Francis Mégraud, Bordeaux, France          
                                                          

10.06 - 10.18
Therapy of H. pylori infection in evolution      
Javier Gisbert, Madrid, Spain                         
                            

10.18 - 10.30
H. pylori screening in the prevention medicine                                                    
Jhy Ming Liou, Taipei, Taiwan

 

10.30 - 10.42
H. pylori in the relationship with other gastric microbiota      
Antonio Gasbarrini, Rome, Italy           

 

10.42 - 10.54
H. pylori treatment and the impact on gut microbiota
Christian Schulz, Munich, Germany

11.00 - 11.30 hrs  Coffee Break

11.30 – 13.00   Symposium 2:  Gastric carcinogenesis

 

11.30 - 11.50
The human stomach epithelial homeostasis recapitulated in-vitro by using mucosoid cultures

Francesco Boccellato, Oxford, UK


11.50 - 12.10
Utility of preclinical models to understand carcinogenesis

Michael Sigal, Berlin, Germany


12.10 - 12.30
Autophagy is necessary for gastric cancer stem cell emergence

Emilie Bessede, Bordeaux, France

12.30 - 12.50
Autoimmune atrophic gastritis and gastric cancer
Marino Venerito, Magdeburg, Germany

13.00 – 14.00 hrs   Lunch Break & Poster Viewing

14.00 – 15.40 hrs   Symposium 3: Microbiota

 

14.00 - 14.20
Gastric microbiota transplantation recapitulates premalignant lesions in germ-free mice

Yong-Chang Lee, Seoul, Korea

14.20 - 14.40
Establishment of gut microbiota in humans
Hakdong Shin, Seoul, Korea

 

14.40 - 15.00
Use of registers in microbiota research
Nele Brusselaers, Stockholm, Sweden

 

15.00 - 15.20
Bidirectional crosstalk between mucins and the microbiota at the level of the GI epithelium
Annemieke Smet, Antwerp, Belgium

 

15.20 - 15.40
New microbiota therapeutics
Harry Sokol, Paris, France

15.45 – 17.15 hrs   Parallel Workshops from Submitted Abstracts W1

15.45 – 17.15 hrs   Parallel Workshops from Submitted Abstracts W2

 

17.15 – 17.45 hrs   Coffee Break

 

17.45 – 19.15 hrs   Parallel Workshops from Submitted Abstracts W3

17.45 – 19.15 hrs   Parallel Workshops from Submitted Abstracts W4

 

20.00 hrs                Networking Dinner

Saturday, September 10, 2022

08.00 – 09.30 hrs   Symposium 4: FMT

 

08.00 - 08.05
Introduction: FMT: from C. difficile towards other indications
Josbert Keller, Leiden, The Netherlands

 

08.05 - 08.25
FMT and immunotherapy: to overcome resistance and to treat immunotherapy induced colitis
Gianluca Ianiro, Rome, Italy

 

08.25 - 08.40
FMT for Inflammatory Bowel diseases: timing and selection of patients and donors
Tariq Iqbal, Birmingham, United Kingdom

08.40 - 09.00
Encapsulation, life bacterial products and regulation
Christian Hvas, Aarhus, Denmark

 

09.00 - 09.15
Introduction of an FMT registry
Maria Vehreschild, Frankfurt, Germany

 

09.15 - 09.30
Investigations of SAE after FMT    
Liz Terveer, Leiden, The Netherlands

09.30 – 10.00 hrs   Coffee Break

10.00 – 11.20 hrs   Symposium 5: H. pylori diagnosis & treatment

 

10.00 - 10.20
New methods for antimicrobial susceptibility testing. The US experience

David Graham, Houston, Texas, USA

10.20 - 10.40
H. pylori rescue treatment. Data from the Hp-EuReg
Olga Nyssen, Madrid, Spain

 

10.40 - 11.00
Use of serum pepsinogen assays in clinical practice
Sun-Young Lee, Seoul, Korea

 

11.00 - 11.20
Impact of probiotics on the faecal resistome during H. pylori eradication
Marcis Leja, Riga, Latvia

11.20 – 12.20 hrs   Industry-Sponsored Satellite Symposium

Click here for more information

12.20 – 13.20 hrs   Lunch Break & Poster Viewing

13.20 – 14.50 hrs   Parallel Workshops from Submitted Abstracts W5

13.20 – 14.50 hrs   Parallel Workshops from Submitted Abstracts W6

14.50 – 15.20 hrs   Coffee Break

15.20 – 16.20 hrs   Symposium 6: Potassium Competitive Acid Blockers (P-CABs)

 

15.20 - 15.40
P-CAB performance from a network meta-analysis
Theodore Rokkas, Athens, Greece

 

15.40 - 16.00
Pharmacological and clinical properties of P-CABs
Colin Howden, Memphis, TN, USA

 

16.00 - 16.20
Long-term experience with P-CABs
Ken Sugano, Shimotsuke City, Japan

16.20 – 17.00 hrs   State of the Art lectures: Looking  to the future

 

16.20 - 16.40
The BioCyc databases: pathways, omics tools and enhanced genome annotation
Ron Caspi, Menlo Park, CA, USA

16.40 - 17.00
New development on gastric cancer treatment
Tamara Matysiak, Nantes, France

 

17.00 – 18.00 hrs   Closing Session

 

17.00 - 17.20

The discovery of H. pylori viewed from the UK  Cliodna McNulty, Gloucester, UK


17.20 - 17.30

Awarding of the Marshall and Warren Medal 2022 to Massimo Rugge, Padova, Italy

17.30 - 17.40
Awarding of the Marshall and Warren Medal 2020 to Hazel Mitchell & 2021 to Dulciene Queiroz

17.40 - 17.50

Awarding of the EHMSG Oral and Poster Awards

17.50 - 18.00
Presentation of the EHMSG Journal

18.00 - 18.10

Presentation of the next meeting in Antwerp
Annemieke Smet, Antwerp, Belgium

 

Closing Remarks